an igg2b variant antibody having the same specificity as campath-1 for human lymphocytes and monocytes is active in antibody-dependent cell-mediated killing ( unlike the parental igg2a ) and may prove to be a valuable therapeutic antibody for immunosuppression and treatment of leukaemia and lymphoma .
C0024264
lymphocytes
C0024299
lymphoma